1.
Borroni RG, Malagoli P, Gargiulo L, Valenti M, Pavia G, Facheris P, Morenghi E, di Corteranzo IG, Narcisi A, Ortoncelli M, Dapavo P, Costanzo A. Real-life Effectiveness and Safety of Risankizumab in Moderate-to-severe Plaque Psoriasis: A 40-week Multicentric Retrospective Study. Acta Derm Venereol [Internet]. 2021 Nov. 30 [cited 2022 May 23];101(11):adv00605. Available from: https://medicaljournalssweden.se/actadv/article/view/283